Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays

A. E. Takemori, G. Y. Ho, J. S. Naeseth, Philip S Portoghese

Research output: Contribution to journalArticle

393 Citations (Scopus)

Abstract

Previously, we reported on an opioid antagonist, nor-binaltorphimine (nor-BNI), that had high selectivity for kappa opioid receptors in smooth muscle preparations. In this study, nor-BNI administered either s.c. or i.c.v. was shown to antagonize significantly the antinociceptive effects of the kappa opioid agonists, ethylketazocine and U-50,488H at doses that had no effect on the antinociceptive effect of mu agonists, morphine and [D-Ala3, MePhe4, Gly-ol5]enkephalin and the delta agonist, [D-Pen3, D-Pen5]enkephalin. Nor-BNI and U-50,488H were used to demonstrate that kappa opioid receptors in the spinal cord were more important than those located supraspinally for kappa-mediated analgesia. Nor-BNI also possessed high affinity and high selectivity for kappa opioid receptors in the receptor binding assay. However, the comparatively low selectivity of BNI in receptor binding studies did not correlatet with the high pharmacologic selectivity for kappa receptors.

Original languageEnglish (US)
Pages (from-to)255-258
Number of pages4
JournalJournal of Pharmacology and Experimental Therapeutics
Volume246
Issue number1
StatePublished - Jan 1 1988

Fingerprint

kappa Opioid Receptor
Narcotic Antagonists
Analgesics
(trans)-Isomer 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide
Ethylketocyclazocine
Enkephalins
Analgesia
Morphine
Opioid Analgesics
Smooth Muscle
Spinal Cord
norbinaltorphimine

Cite this

Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. / Takemori, A. E.; Ho, G. Y.; Naeseth, J. S.; Portoghese, Philip S.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 246, No. 1, 01.01.1988, p. 255-258.

Research output: Contribution to journalArticle

@article{982320c7d077444c8f9113015017415c,
title = "Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays",
abstract = "Previously, we reported on an opioid antagonist, nor-binaltorphimine (nor-BNI), that had high selectivity for kappa opioid receptors in smooth muscle preparations. In this study, nor-BNI administered either s.c. or i.c.v. was shown to antagonize significantly the antinociceptive effects of the kappa opioid agonists, ethylketazocine and U-50,488H at doses that had no effect on the antinociceptive effect of mu agonists, morphine and [D-Ala3, MePhe4, Gly-ol5]enkephalin and the delta agonist, [D-Pen3, D-Pen5]enkephalin. Nor-BNI and U-50,488H were used to demonstrate that kappa opioid receptors in the spinal cord were more important than those located supraspinally for kappa-mediated analgesia. Nor-BNI also possessed high affinity and high selectivity for kappa opioid receptors in the receptor binding assay. However, the comparatively low selectivity of BNI in receptor binding studies did not correlatet with the high pharmacologic selectivity for kappa receptors.",
author = "Takemori, {A. E.} and Ho, {G. Y.} and Naeseth, {J. S.} and Portoghese, {Philip S}",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "246",
pages = "255--258",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays

AU - Takemori, A. E.

AU - Ho, G. Y.

AU - Naeseth, J. S.

AU - Portoghese, Philip S

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Previously, we reported on an opioid antagonist, nor-binaltorphimine (nor-BNI), that had high selectivity for kappa opioid receptors in smooth muscle preparations. In this study, nor-BNI administered either s.c. or i.c.v. was shown to antagonize significantly the antinociceptive effects of the kappa opioid agonists, ethylketazocine and U-50,488H at doses that had no effect on the antinociceptive effect of mu agonists, morphine and [D-Ala3, MePhe4, Gly-ol5]enkephalin and the delta agonist, [D-Pen3, D-Pen5]enkephalin. Nor-BNI and U-50,488H were used to demonstrate that kappa opioid receptors in the spinal cord were more important than those located supraspinally for kappa-mediated analgesia. Nor-BNI also possessed high affinity and high selectivity for kappa opioid receptors in the receptor binding assay. However, the comparatively low selectivity of BNI in receptor binding studies did not correlatet with the high pharmacologic selectivity for kappa receptors.

AB - Previously, we reported on an opioid antagonist, nor-binaltorphimine (nor-BNI), that had high selectivity for kappa opioid receptors in smooth muscle preparations. In this study, nor-BNI administered either s.c. or i.c.v. was shown to antagonize significantly the antinociceptive effects of the kappa opioid agonists, ethylketazocine and U-50,488H at doses that had no effect on the antinociceptive effect of mu agonists, morphine and [D-Ala3, MePhe4, Gly-ol5]enkephalin and the delta agonist, [D-Pen3, D-Pen5]enkephalin. Nor-BNI and U-50,488H were used to demonstrate that kappa opioid receptors in the spinal cord were more important than those located supraspinally for kappa-mediated analgesia. Nor-BNI also possessed high affinity and high selectivity for kappa opioid receptors in the receptor binding assay. However, the comparatively low selectivity of BNI in receptor binding studies did not correlatet with the high pharmacologic selectivity for kappa receptors.

UR - http://www.scopus.com/inward/record.url?scp=0023812719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023812719&partnerID=8YFLogxK

M3 - Article

VL - 246

SP - 255

EP - 258

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -